| Up
2005P-0066:
ANDA Suitability for Amlodipine Besylate Capsules 2.5, 5, and 10
mg
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Document #
|
| Received Date
|
| Filed
Date
|
| Submitter Code
|
| Submitter
|
| FR
Date
|
| FR
Page
|
| Comment Date
|
| Files
|
| Remarks
|
|
|
|
|
|
|
| CP1
|
| 02/14/2005
|
| 02/14/2005
|
| Private Industry
|
| DLA Piper Rudnick
Gray Cary
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| David Rosen, B.S. Pharm., J.D.
|
|
|
|
|
| ACK1
|
| 02/14/2005
|
| 02/14/2005
|
| Federal Government
|
| HFA-305 to DLA Piper
Rudnick Gray Cary
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
|
|
| Signature:
|
| Jennie C. Butler
|
|
|
|
|
| SUP1
|
| 03/30/2005
|
| 03/29/2005
|
| Private Industry
|
| Foley & Lardner
LLP
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| David L. Rosen, B.S. Pharm.,
J.D.
|
|
|
|
|
| SUP2
|
| 04/01/2005
|
| 03/31/2005
|
| Private Industry
|
| Foley & Lardner
LLP
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| David L. Rosen, B.S. Pharm.,
J.D.
| |
|
|
|
| PDN1
|
| 06/08/2006
|
| 06/08/2006
|
| Federal Government
|
| FDA/CDER to DLA Piper
Rudnick Gray Cary US LLP
|
|
|
|
|
|
|
| pdf
|
|
|
|
|
| Signature:
|
| Gary J. Buehler
| |
Top | Up
Page last updated
July 17, 2006
kk
Dockets Home Page | Dockets
Contacts and Location | Operating
Status | Item
Code Definitions | Federal
Register
FDA Home Page | Search
FDA Site | FDA A-Z Index
| Contact FDA
FDA/Dockets Management |
